ArticleVeterinary research communications2026
Immune response in honey bees (Apis mellifera) following humic substance feeding.
Article in Veterinary research communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Humic substances (HS) are increasingly investigated as natural additives to support health in humans and animals, yet their effects on honey bees remain insufficiently characterised. This study evaluated the impact of a commercial HS-based product on immunity and oxidative status of Apis mellifera. Newly emerged worker bees were kept under laboratory conditions and fed sugar syrup supplemented with 0.5% HS for seven days, while the control group received unsupplemented syrup. Effects of HS were evaluated by analysing the expression of selected immune-related genes, quantifying antimicrobial peptides (AMPs), measuring the activity of antioxidant enzymes, evaluating lipid peroxidation, and characterising hemocyte populations. HS supplementation significantly increased relative gene expression of superoxide dismutase 1 and prophenoloxidase, while expression of genes for apidaecin and defensin 1 decreased. HS supplementation significantly increased relative gene expression of superoxide dismutase 1 and prophenoloxidase, while expression of genes for apidaecin and defensin 1 decreased. Similarly, catalase enzymatic activity was significantly decreased in the HS group. No significant changes were detected in gene expression for other AMPs and relative abundance of AMPs, or other antioxidant parameters. HS supplementation significantly increased the proportion of medium granular hemocytes (p < 0.05) at the expense of high granular cells (p < 0.01). In conclusion, the 7-day administration of HS at 0.5% did not adversely affect bee health and modulated selected immune parameters. The biological significance of these immunomodulatory effects requires confirmation through challenge studies and field trials under natural conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.